10 20 30 40 50 60 70 80 1YML - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE, CELL CYCLE 21-JAN-05 1YML
TITLE CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC TITLE 2 DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE SULFENIC FORM
COMPND MOL_ID: 1; COMPND 2 MOLECULE: M-PHASE INDUCER PHOSPHATASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: CDC25B PHOSPHATASE; DUAL SPECIFICITY PHOSPHATASE COMPND 6 CDC25B; COMPND 7 EC: 3.1.3.48; COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDC25B, CDC25HU2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS SULFENIC CYSTEINE, HYDROLASE, CELL CYCLE
EXPDTA X-RAY DIFFRACTION
AUTHOR G.K.BUHRMAN,B.PARKER,J.SOHN,J.RUDOLPH,C.MATTOS
REVDAT 2 24-FEB-09 1YML 1 VERSN REVDAT 1 12-APR-05 1YML 0
JRNL AUTH G.K.BUHRMAN,B.PARKER,J.SOHN,J.RUDOLPH,C.MATTOS JRNL TITL STRUCTURAL MECHANISM OF OXIDATIVE REGULATION OF JRNL TITL 2 THE PHOSPHATASE CDC25B VIA AN INTRAMOLECULAR JRNL TITL 3 DISULFIDE BOND JRNL REF BIOCHEMISTRY V. 44 5307 2005 JRNL REFN ISSN 0006-2960 JRNL PMID 15807524 JRNL DOI 10.1021/BI047449FS0006-2960(04)07449-5
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 377118.590 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 29267 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2919 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4149 REMARK 3 BIN R VALUE (WORKING SET) : 0.2190 REMARK 3 BIN FREE R VALUE : 0.2440 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 475 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1428 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 172 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.09000 REMARK 3 B22 (A**2) : -2.28000 REMARK 3 B33 (A**2) : -0.81000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.06 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.10 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.60 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.73 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.510 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.220 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.820 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.600 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 24.29 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN3.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN3.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1YML COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-FEB-05. REMARK 100 THE RCSB ID CODE IS RCSB031688.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29267 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 35.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1QB0 REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: DTT,TRIS, AMMONIUM SULFATE, PH REMARK 280 7.25, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 100.0K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.93350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.15000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.54050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.15000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.93350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.54050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A MONOMER
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 461 REMARK 465 SER A 462 REMARK 465 LEU A 463 REMARK 465 ASP A 464
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 439 -6.41 80.87 REMARK 500 PHE A 475 -120.37 -136.36 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1001
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC REMARK 900 DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE SULFINIC FORM REMARK 900 RELATED ID: 1YMD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC REMARK 900 DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE SULFONIC FORM REMARK 900 RELATED ID: 1YMK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC REMARK 900 DOMAIN IN THE APO FORM REMARK 900 RELATED ID: 1YS0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC REMARK 900 DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE DISULFIDE FORM
DBREF 1YML A 377 550 UNP P30305 MPIP2_HUMAN 391 564
SEQADV 1YML MET A 376 UNP P30305 INITIATING METHIONINE SEQADV 1YML CSO A 473 UNP P30305 CYS 487 MODIFIED RESIDUE
SEQRES 1 A 175 MET GLU LEU ILE GLY ASP TYR SER LYS ALA PHE LEU LEU SEQRES 2 A 175 GLN THR VAL ASP GLY LYS HIS GLN ASP LEU LYS TYR ILE SEQRES 3 A 175 SER PRO GLU THR MET VAL ALA LEU LEU THR GLY LYS PHE SEQRES 4 A 175 SER ASN ILE VAL ASP LYS PHE VAL ILE VAL ASP CYS ARG SEQRES 5 A 175 TYR PRO TYR GLU TYR GLU GLY GLY HIS ILE LYS THR ALA SEQRES 6 A 175 VAL ASN LEU PRO LEU GLU ARG ASP ALA GLU SER PHE LEU SEQRES 7 A 175 LEU LYS SER PRO ILE ALA PRO CYS SER LEU ASP LYS ARG SEQRES 8 A 175 VAL ILE LEU ILE PHE HIS CSO GLU PHE SER SER GLU ARG SEQRES 9 A 175 GLY PRO ARG MET CYS ARG PHE ILE ARG GLU ARG ASP ARG SEQRES 10 A 175 ALA VAL ASN ASP TYR PRO SER LEU TYR TYR PRO GLU MET SEQRES 11 A 175 TYR ILE LEU LYS GLY GLY TYR LYS GLU PHE PHE PRO GLN SEQRES 12 A 175 HIS PRO ASN PHE CYS GLU PRO GLN ASP TYR ARG PRO MET SEQRES 13 A 175 ASN HIS GLU ALA PHE LYS ASP GLU LEU LYS THR PHE ARG SEQRES 14 A 175 LEU LYS THR ARG SER TRP
MODRES 1YML CSO A 473 CYS S-HYDROXYCYSTEINE
HET CSO A 473 7 HET CL A1001 1
HETNAM CSO S-HYDROXYCYSTEINE HETNAM CL CHLORIDE ION
FORMUL 1 CSO C3 H7 N O3 S FORMUL 2 CL CL 1- FORMUL 3 HOH *172(H2 O)
HELIX 1 1 SER A 402 THR A 411 1 10 HELIX 2 2 TYR A 428 GLY A 434 1 7 HELIX 3 3 LEU A 445 LYS A 455 1 11 HELIX 4 4 GLU A 478 VAL A 494 1 17 HELIX 5 5 GLY A 510 PHE A 516 1 7 HELIX 6 6 HIS A 519 ASN A 521 5 3 HELIX 7 7 HIS A 533 ALA A 535 5 3 HELIX 8 8 PHE A 536 LEU A 545 1 10
SHEET 1 A 5 TYR A 400 ILE A 401 0 SHEET 2 A 5 MET A 505 LEU A 508 1 O ILE A 507 N ILE A 401 SHEET 3 A 5 ARG A 466 HIS A 472 1 N PHE A 471 O TYR A 506 SHEET 4 A 5 VAL A 418 ASP A 425 1 N VAL A 424 O ILE A 470 SHEET 5 A 5 VAL A 441 ASN A 442 1 O VAL A 441 N ILE A 423 SHEET 1 B 2 HIS A 436 ILE A 437 0 SHEET 2 B 2 CYS A 523 GLU A 524 -1 O GLU A 524 N HIS A 436
LINK C HIS A 472 N CSO A 473 1555 1555 1.34 LINK C CSO A 473 N GLU A 474 1555 1555 1.33
CISPEP 1 TYR A 497 PRO A 498 0 -0.15 CISPEP 2 GLU A 524 PRO A 525 0 -1.21
SITE 1 AC1 3 HOH A 100 GLU A 446 ARG A 548
CRYST1 49.867 71.081 74.300 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.020053 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014068 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013459 0.00000